General Anesthesia Drug Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

May 2025 | 93 pages | ID: GEF57483E3B0EN
Prof Research

Abstracts

General Anesthesia Drugs Market Summary

Introduction and Market Overview

General anesthesia drugs, including intravenous (propofol, etomidate, midazolam, fentanyl, remimazolam) and inhaled (sevoflurane, desflurane, isoflurane) agents, support approximately 234 million major surgeries annually, driven by chronic diseases like cardiovascular disorders (10,000 daily deaths in Europe) and cancer (24 million cases projected by 2030). The market is propelled by an aging population (1 billion over 60 in 2020, projected to reach 2.1 billion by 2050), with 1 in 7 U.S. Medicare beneficiaries undergoing major surgery within five years. Novel drugs like remimazolam reduce side effects by 20%, and low-flow inhalation systems cut desflurane use by 30%. The global general anesthesia drugs market is estimated at USD 3.0-5.0 billion in 2025, with a CAGR of 3%-7% through 2030.

Regional Market Trends

• North America: The U.S. leads with high surgical volumes and remimazolam adoption, while Canada emphasizes outpatient surgeries.
• Europe: Germany, France, and the UK drive growth with advanced surgical care.
• Asia Pacific: China and India see rising surgical demand due to chronic diseases, with Japan focusing on safety innovations.
• Rest of the World: Brazil expands surgical infrastructure, while the Middle East addresses cardiovascular surgeries.

Application Analysis

• Hospitals: Expected growth of 3.5%-7.5%, driven by major surgeries. Trends focus on specialized operating rooms.
• Ambulatory Surgical Centers: Projected growth of 3.8%-7.8%, linked to outpatient procedures. Advances emphasize rapid recovery.
• Others: Anticipated growth of 3.0%-7.0%, covering emergency settings. Trends highlight portable anesthesia systems.

Type Analysis

• Intravenous: Expected growth of 3.8%-7.8%, favored for rapid onset. Trends focus on remimazolam and propofol innovations.
• Inhaled: Projected growth of 3.5%-7.5%, for sustained anesthesia. Advances emphasize low-flow sevoflurane systems.

Intravenous Subtypes:

? Propofol: Expected growth of 3.7%-7.7%, widely used for induction. Trends highlight safety enhancements.

? Etomidate: Projected growth of 3.5%-7.5%, for high-risk patients. Advances focus on cardiovascular stability.

? Midazolam: Anticipated growth of 3.4%-7.4%, for sedation. Trends emphasize adjunctive use.

? Fentanyl: Expected growth of 3.6%-7.6%, for pain management. Developments prioritize dosing precision.

? Remimazolam: Projected growth of 4.0%-8.0%, reducing side effects. Trends highlight rapid recovery.

? Others: Anticipated growth of 3.3%-7.3%, covering emerging agents. Trends focus on novel formulations.

Inhaled Subtypes:

? Sevoflurane: Expected growth of 3.6%-7.6%, for maintenance. Trends emphasize low-flow delivery.

? Desflurane: Projected growth of 3.5%-7.5%, for rapid recovery. Advances focus on cost reduction.

? Isoflurane: Anticipated growth of 3.4%-7.4%, cost-effective option. Trends highlight use in developing regions.

? Others: Expected growth of 3.3%-7.3%, covering niche agents. Developments prioritize environmental impact.

Key Market Players

• Pfizer: Supplies propofol and fentanyl for anesthesia.
• Fresenius Kabi: Offers intravenous anesthesia agents.
• Hikma Pharmaceuticals: Provides affordable anesthesia drugs.
• Baxter International: Develops inhaled anesthesia solutions.
• AbbVie: Innovates sedation and pain management drugs.

Porter’s Five Forces Analysis

• Threat of New Entrants: Moderate, as high R&D costs and regulatory hurdles exist, but generics lower barriers.
• Threat of Substitutes: Low, as general anesthesia is essential for major surgeries, with few alternatives.
• Bargaining Power of Buyers: Moderate, as hospitals negotiate prices, but critical drugs limit leverage.
• Bargaining Power of Suppliers: Low, with multiple suppliers of active ingredients.
• Competitive Rivalry: High, with companies competing on safety, cost, and innovation.

Market Opportunities and Challenges

Opportunities:

• Supporting 234 million annual surgeries globally.
• Addressing chronic diseases, with 24 million cancer cases by 2030.
• Leveraging an aging population, projected at 2.1 billion by 2050.
• Utilizing novel drugs, reducing side effects by 20%.
• Implementing low-flow systems, cutting desflurane use by 30%.
• Expanding surgical access in developing regions.

Challenges:

• High costs of novel anesthesia drugs limiting adoption.
• Regulatory delays for new formulations.
• Environmental concerns with inhaled anesthetics.
• Shortages of critical anesthesia drugs.
• Limited surgical infrastructure in low-income regions.

Contents

CHAPTER 1 EXECUTIVE SUMMARY

CHAPTER 2 ABBREVIATION AND ACRONYMS

CHAPTER 3 PREFACE

3.1 Research Scope
3.2 Research Sources
  3.2.1 Data Sources
  3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

CHAPTER 5 MARKET TREND ANALYSIS

5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats

CHAPTER 6 INDUSTRY CHAIN ANALYSIS

6.1 Upstream/Suppliers Analysis
6.2 General Anesthesia Drug Analysis
  6.2.1 Technology Analysis
  6.2.2 Cost Analysis
  6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

CHAPTER 7 LATEST MARKET DYNAMICS

7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

CHAPTER 8 HISTORICAL AND FORECAST GENERAL ANESTHESIA DRUG MARKET IN NORTH AMERICA (2020-2030)

8.1 General Anesthesia Drug Market Size
8.2 General Anesthesia Drug Market by End Use
8.3 Competition by Players/Suppliers
8.4 General Anesthesia Drug Market Size by Type
8.5 Key Countries Analysis
  8.5.1 United States
  8.5.2 Canada
  8.5.3 Mexico

CHAPTER 9 HISTORICAL AND FORECAST GENERAL ANESTHESIA DRUG MARKET IN SOUTH AMERICA (2020-2030)

9.1 General Anesthesia Drug Market Size
9.2 General Anesthesia Drug Market by End Use
9.3 Competition by Players/Suppliers
9.4 General Anesthesia Drug Market Size by Type
9.5 Key Countries Analysis
  9.5.1 Brazil
  9.5.2 Argentina
  9.5.3 Chile
  9.5.4 Peru

CHAPTER 10 HISTORICAL AND FORECAST GENERAL ANESTHESIA DRUG MARKET IN ASIA & PACIFIC (2020-2030)

10.1 General Anesthesia Drug Market Size
10.2 General Anesthesia Drug Market by End Use
10.3 Competition by Players/Suppliers
10.4 General Anesthesia Drug Market Size by Type
10.5 Key Countries Analysis
  10.5.1 China
  10.5.2 India
  10.5.3 Japan
  10.5.4 South Korea
  10.5.5 Southest Asia
  10.5.6 Australia

CHAPTER 11 HISTORICAL AND FORECAST GENERAL ANESTHESIA DRUG MARKET IN EUROPE (2020-2030)

11.1 General Anesthesia Drug Market Size
11.2 General Anesthesia Drug Market by End Use
11.3 Competition by Players/Suppliers
11.4 General Anesthesia Drug Market Size by Type
11.5 Key Countries Analysis
  11.5.1 Germany
  11.5.2 France
  11.5.3 United Kingdom
  11.5.4 Italy
  11.5.5 Spain
  11.5.6 Belgium
  11.5.7 Netherlands
  11.5.8 Austria
  11.5.9 Poland
  11.5.10 Russia

CHAPTER 12 HISTORICAL AND FORECAST GENERAL ANESTHESIA DRUG MARKET IN MEA (2020-2030)

12.1 General Anesthesia Drug Market Size
12.2 General Anesthesia Drug Market by End Use
12.3 Competition by Players/Suppliers
12.4 General Anesthesia Drug Market Size by Type
12.5 Key Countries Analysis
  12.5.1 Egypt
  12.5.2 Israel
  12.5.3 South Africa
  12.5.4 Gulf Cooperation Council Countries
  12.5.5 Turkey

CHAPTER 13 SUMMARY FOR GLOBAL GENERAL ANESTHESIA DRUG MARKET (2020-2025)

13.1 General Anesthesia Drug Market Size
13.2 General Anesthesia Drug Market by End Use
13.3 Competition by Players/Suppliers
13.4 General Anesthesia Drug Market Size by Type

CHAPTER 14 GLOBAL GENERAL ANESTHESIA DRUG MARKET FORECAST (2025-2030)

14.1 General Anesthesia Drug Market Size Forecast
14.2 General Anesthesia Drug Application Forecast
14.3 Competition by Players/Suppliers
14.4 General Anesthesia Drug Type Forecast

CHAPTER 15 ANALYSIS OF GLOBAL KEY VENDORS

15.1 Pfizer
  15.1.1 Company Profile
  15.1.2 Main Business and General Anesthesia Drug Information
  15.1.3 SWOT Analysis of Pfizer
  15.1.4 Pfizer General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.2 Fresenius Kabi
  15.2.1 Company Profile
  15.2.2 Main Business and General Anesthesia Drug Information
  15.2.3 SWOT Analysis of Fresenius Kabi
  15.2.4 Fresenius Kabi General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.3 Hikama Pharmaceuticals
  15.3.1 Company Profile
  15.3.2 Main Business and General Anesthesia Drug Information
  15.3.3 SWOT Analysis of Hikama Pharmaceuticals
  15.3.4 Hikama Pharmaceuticals General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.4 Baxter International
  15.4.1 Company Profile
  15.4.2 Main Business and General Anesthesia Drug Information
  15.4.3 SWOT Analysis of Baxter International
  15.4.4 Baxter International General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.5 AbbVie
  15.5.1 Company Profile
  15.5.2 Main Business and General Anesthesia Drug Information
  15.5.3 SWOT Analysis of AbbVie
  15.5.4 AbbVie General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.6 PAION AG
  15.6.1 Company Profile
  15.6.2 Main Business and General Anesthesia Drug Information
  15.6.3 SWOT Analysis of PAION AG
  15.6.4 PAION AG General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
15.7 AstraZeneca
  15.7.1 Company Profile
  15.7.2 Main Business and General Anesthesia Drug Information
  15.7.3 SWOT Analysis of AstraZeneca
  15.7.4 AstraZeneca General Anesthesia Drug Revenue, Gross Margin and Market Share (2020-2025)
Please ask for sample pages for full companies list
Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of General Anesthesia Drug Report
Table Data Sources of General Anesthesia Drug Report
Table Major Assumptions of General Anesthesia Drug Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure General Anesthesia Drug Picture
Table General Anesthesia Drug Classification
Table General Anesthesia Drug Applications
Table Drivers of General Anesthesia Drug Market
Table Restraints of General Anesthesia Drug Market
Table Opportunities of General Anesthesia Drug Market
Table Threats of General Anesthesia Drug Market
Table Covid-19 Impact For General Anesthesia Drug Market
Table Raw Materials Suppliers
Table Different Production Methods of General Anesthesia Drug
Table Cost Structure Analysis of General Anesthesia Drug
Table Key End Users
Table Latest News of General Anesthesia Drug Market
Table Merger and Acquisition
Table Planned/Future Project of General Anesthesia Drug Market
Table Policy of General Anesthesia Drug Market
Table 2020-2030 North America General Anesthesia Drug Market Size
Figure 2020-2030 North America General Anesthesia Drug Market Size and CAGR
Table 2020-2030 North America General Anesthesia Drug Market Size by Application
Table 2020-2025 North America General Anesthesia Drug Key Players Revenue
Table 2020-2025 North America General Anesthesia Drug Key Players Market Share
Table 2020-2030 North America General Anesthesia Drug Market Size by Type
Table 2020-2030 United States General Anesthesia Drug Market Size
Table 2020-2030 Canada General Anesthesia Drug Market Size
Table 2020-2030 Mexico General Anesthesia Drug Market Size
Table 2020-2030 South America General Anesthesia Drug Market Size
Figure 2020-2030 South America General Anesthesia Drug Market Size and CAGR
Table 2020-2030 South America General Anesthesia Drug Market Size by Application
Table 2020-2025 South America General Anesthesia Drug Key Players Revenue
Table 2020-2025 South America General Anesthesia Drug Key Players Market Share
Table 2020-2030 South America General Anesthesia Drug Market Size by Type
Table 2020-2030 Brazil General Anesthesia Drug Market Size
Table 2020-2030 Argentina General Anesthesia Drug Market Size
Table 2020-2030 Chile General Anesthesia Drug Market Size
Table 2020-2030 Peru General Anesthesia Drug Market Size
Table 2020-2030 Asia & Pacific General Anesthesia Drug Market Size
Figure 2020-2030 Asia & Pacific General Anesthesia Drug Market Size and CAGR
Table 2020-2030 Asia & Pacific General Anesthesia Drug Market Size by Application
Table 2020-2025 Asia & Pacific General Anesthesia Drug Key Players Revenue
Table 2020-2025 Asia & Pacific General Anesthesia Drug Key Players Market Share
Table 2020-2030 Asia & Pacific General Anesthesia Drug Market Size by Type
Table 2020-2030 China General Anesthesia Drug Market Size
Table 2020-2030 India General Anesthesia Drug Market Size
Table 2020-2030 Japan General Anesthesia Drug Market Size
Table 2020-2030 South Korea General Anesthesia Drug Market Size
Table 2020-2030 Southeast Asia General Anesthesia Drug Market Size
Table 2020-2030 Australia General Anesthesia Drug Market Size
Table 2020-2030 Europe General Anesthesia Drug Market Size
Figure 2020-2030 Europe General Anesthesia Drug Market Size and CAGR
Table 2020-2030 Europe General Anesthesia Drug Market Size by Application
Table 2020-2025 Europe General Anesthesia Drug Key Players Revenue
Table 2020-2025 Europe General Anesthesia Drug Key Players Market Share
Table 2020-2030 Europe General Anesthesia Drug Market Size by Type
Table 2020-2030 Germany General Anesthesia Drug Market Size
Table 2020-2030 France General Anesthesia Drug Market Size
Table 2020-2030 United Kingdom General Anesthesia Drug Market Size
Table 2020-2030 Italy General Anesthesia Drug Market Size
Table 2020-2030 Spain General Anesthesia Drug Market Size
Table 2020-2030 Belgium General Anesthesia Drug Market Size
Table 2020-2030 Netherlands General Anesthesia Drug Market Size
Table 2020-2030 Austria General Anesthesia Drug Market Size
Table 2020-2030 Poland General Anesthesia Drug Market Size
Table 2020-2030 Russia General Anesthesia Drug Market Size
Table 2020-2030 MEA General Anesthesia Drug Market Size
Figure 2020-2030 MEA General Anesthesia Drug Market Size and CAGR
Table 2020-2030 MEA General Anesthesia Drug Market Size by Application
Table 2020-2025 MEA General Anesthesia Drug Key Players Revenue
Table 2020-2025 MEA General Anesthesia Drug Key Players Market Share
Table 2020-2030 MEA General Anesthesia Drug Market Size by Type
Table 2020-2030 Egypt General Anesthesia Drug Market Size
Table 2020-2030 Israel General Anesthesia Drug Market Size
Table 2020-2030 South Africa General Anesthesia Drug Market Size
Table 2020-2030 Gulf Cooperation Council Countries General Anesthesia Drug Market Size
Table 2020-2030 Turkey General Anesthesia Drug Market Size
Table 2020-2025 Global General Anesthesia Drug Market Size by Region
Table 2020-2025 Global General Anesthesia Drug Market Size Share by Region
Table 2020-2025 Global General Anesthesia Drug Market Size by Application
Table 2020-2025 Global General Anesthesia Drug Market Share by Application
Table 2020-2025 Global General Anesthesia Drug Key Vendors Revenue
Figure 2020-2025 Global General Anesthesia Drug Market Size and Growth Rate
Table 2020-2025 Global General Anesthesia Drug Key Vendors Market Share
Table 2020-2025 Global General Anesthesia Drug Market Size by Type
Table 2020-2025 Global General Anesthesia Drug Market Share by Type
Table 2025-2030 Global General Anesthesia Drug Market Size by Region
Table 2025-2030 Global General Anesthesia Drug Market Size Share by Region
Table 2025-2030 Global General Anesthesia Drug Market Size by Application
Table 2025-2030 Global General Anesthesia Drug Market Share by Application
Table 2025-2030 Global General Anesthesia Drug Key Vendors Revenue
Figure 2025-2030 Global General Anesthesia Drug Market Size and Growth Rate
Table 2025-2030 Global General Anesthesia Drug Key Vendors Market Share
Table 2025-2030 Global General Anesthesia Drug Market Size by Type
Table 2025-2030 General Anesthesia Drug Global Market Share by Type